A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)

Clinical trial NCT07037758 · RECRUITING

Trial details

NCT number: NCT07037758
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Extensive Stage Small Cell Lung Cancer

Start date: 2025-09-16
Primary completion: 2028-03-18
Enrollment: 380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.